A detailed history of Balyasny Asset Management LLC transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,725,562 shares of TOI stock, worth $483,157. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,725,562
Previous 1,725,562 -0.0%
Holding current value
$483,157
Previous $2.73 Million 70.91%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.36 - $2.3 $642,634 - $1.09 Million
472,525 Added 37.71%
1,725,562 $2.73 Million
Q4 2023

Feb 14, 2024

BUY
$1.14 - $2.55 $929,622 - $2.08 Million
815,458 Added 186.36%
1,253,037 $2.56 Million
Q3 2023

Nov 14, 2023

BUY
$0.5 - $1.66 $218,789 - $726,381
437,579 New
437,579 $612,000
Q2 2022

Aug 15, 2022

SELL
$4.78 - $9.89 $51,972 - $107,533
-10,873 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.97 - $9.85 $43,165 - $107,099
10,873 New
10,873 $78,000

Others Institutions Holding TOI

About Oncology Institute, Inc.


  • Ticker TOI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 73,495,504
  • Market Cap $20.6M
  • Description
  • The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...
More about TOI
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.